Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA To Provide Updates On Agency Involvement In Critical Path Projects

This article was originally published in The Pink Sheet Daily

Executive Summary

Agency opportunities list highlights 76 “scientific projects” that could modernize the medical product development process.

You may also be interested in...



Von Eschenbach Disappointed With Critical Path Progress

FDA Commissioner tells Maryland biotech audience he wants FDA to be a bridge rather than a barrier to life science advances.

Von Eschenbach Disappointed With Critical Path Progress

FDA Commissioner tells Maryland biotech audience he wants FDA to be a bridge rather than a barrier to life science advances.

Gene Logic To Share Genomic Data With FDA For Critical Path Initiative

Voluntary collaboration will help FDA develop quality standards for submission of microarray data.

Related Content

Topics

UsernamePublicRestriction

Register

LL043624

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel